Clinical Trials Directory

Trials / Completed

CompletedNCT05233800

mHealth for Breast Cancer Survivors With Insomnia

Testing mHealth Delivery of Cognitive Behavioral Therapy for Insomnia to Breast Cancer Survivors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
76 (actual)
Sponsor
Medstar Health Research Institute · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine the impact of the voice-activated smart speaker CBT-I components on insomnia symptoms among breast cancer survivors using a randomized clinical trial.

Detailed description

This study is a Phase II SBIR to further test efficacy of a voice-activated technology to deliver components of cognitive behavioral therapy for insomnia (CBT-I) to breast cancer survivors (BCS) compared to a web-based control. Participants will be randomly assigned to the voice-activated or web-based treatment arms and will complete a 6-week intervention.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFaster Asleep Smart Speaker ProgramParticipants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
BEHAVIORALFaster Asleep WebsiteControls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.

Timeline

Start date
2022-04-05
Primary completion
2023-12-15
Completion
2023-12-15
First posted
2022-02-10
Last updated
2025-01-24
Results posted
2025-01-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05233800. Inclusion in this directory is not an endorsement.